Workflow
BREAKING: aTyr Pharma Shares Plummet 80%; Investors Should Contact Block & Leviton to Potentially Recover Losses

BOSTON, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating aTyr Pharma, Inc. (Nasdaq: ATYR) for potential securities law violations. Investors who have lost money in their aTyr Pharma, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/atyr. What is this all about? Block & Leviton is investigating aTyr Pharma after the company announced that its Phase 3 trial for efzofitimod, an experimental ...